Surgical-grade tools for reconstitution, dosing, half-life modelling, and schedule planning. Built for researchers and biohackers.
Wipe vial tops with 70% isopropyl alcohol swab.
Draw 2.00 mL of bacteriostatic water into your syringe.
Inject the BAC water down the side of the peptide vial. Do not aim directly at the powder.
Swirl (do not shake) until fully dissolved and clear.
Draw 0.10 mL (10.0 IU on syringe) for each 250 mcg dose.
Refrigerate reconstituted vial at 2–8°C. Use within 28–30 days.
| Peptide | Vial | BAC Water | Concentration | 250mcg dose | Doses |
|---|---|---|---|---|---|
| BPC-157 | 5 mg | 2 mL | 2.5 mg/mL | 10 IU (0.1 mL) | 20 |
| TB-500 | 10 mg | 2 mL | 5 mg/mL | 5 IU (0.05 mL) | 40 |
| Semaglutide | 5 mg | 2 mL | 2.5 mg/mL | 10 IU (0.1 mL) | 20 |
| Tirzepatide | 10 mg | 2 mL | 5 mg/mL | 5 IU (0.05 mL) | 40 |
| Retatrutide | 10 mg | 2 mL | 5 mg/mL | 5 IU (0.05 mL) | 40 |
| Ipamorelin | 5 mg | 2 mL | 2.5 mg/mL | 10 IU (0.1 mL) | 20 |
Loading…
| Compound | Half-Life | Steady State | Accumulation | Dosing |
|---|---|---|---|---|
| Retatrutide | ~144h (6 days) | ~4–5 weeks | 7× | Once weekly |
| Tirzepatide | ~120h (5 days) | ~3–4 weeks | 5× | Once weekly |
| Semaglutide | ~168h (7 days) | ~4–5 weeks | 8× | Once weekly |
| CJC-1295 DAC | ~192h (8 days) | ~5–6 weeks | 9× | Once weekly |
| TB-500 | ~72h (3 days) | ~2–3 weeks | 2.3× | EOD / Weekly |
| BPC-157 | ~4h | ~1–2 days | ~1× | ED / BID |
| Ipamorelin | ~2h | ~12h | ~1× | BID / TID |
| Metric | Value |
|---|---|
| Per-injection dose | — |
| Peak concentration (SS) | — |
| Trough concentration (SS) | — |
| Peak-to-trough ratio | — |
| Peak reduction vs 1×/week | — |
| Days to steady state | — |
⚠️ Critical Research Disclaimer: Microdosing GLP-1 agonists is not clinically studied. These calculations are based on pharmacokinetic modeling, not clinical trials. Always consult a licensed physician before altering any dosage or frequency.